Cardica eyes Japanese approval; Genova angles to get bought;

@FierceMedDev: Kona snags ex-SonoSite exec to helm renal denervation. Article | Follow @FierceMedDev

@DamianFierce: Medtronic is spending $200M on a telehealth outfit with an eye on slashing healthcare costs. News | Follow @DamianFierce

@MichaelGFierce: New antivirus system could protect medical devices from infection. Article | Follow @MichaelGFierce

> Cardica ($CRDC) and partner Century Medical are seeking Japanese approval for the MicroCutter Xchange device. News

> Genova Diagnostics has hired an investment bank to help it sell itself, according to Dow Jones. Article

> The FDA has assigned its most-serious Class I label to Iradimed's recall of an infusion pump component. More

> Ariosa Diagnostics has teamed up with Canadian researchers to conduct a large-scale comparative effectiveness study on noninvasive prenatal screening techniques. Release

> Eureka Genomics has signed up to provide sequencing services for Life Technologies' ($LIFE) Ion Torrent Proton system. Item

Biotech News

@FierceBiotech: Icon signs up to boost Taiwan's stake in drug development. FierceCRO article | Release | Follow @FierceBiotech

@JohnCFierce: If Roche does try to buy Alexion, the company is going to get slaughtered by the analysts. More | Follow @JohnCFierce

@RyanMFierce: CollabRx elbows into software game for gene interpretation. FierceBiotech IT story | Follow @RyanMFierce

@EmilyMFierce: Newly discovered proteins could play role in destroying cancer cells. More from FierceBiotech Research | Follow @EmilyMFierce

> Biotechs crowd list of top growth leaders as Big Pharmas shrink staffs. Feature

> Which are the most efficient drug developers in biopharma? More

> Vical discards melanoma immunotherapy Allovectin after PhIII failure. Report

Pharma News

@FiercePharma: Still trending: Pharma professionals feeling angst, but see a few rays of hope. Story | Follow @FiercePharma

@EricPFierce: India's Aurobindo puts sterile injectables unit into a subsidiary to unlock value. Wonder if it will shop it next? Story | Follow @EricPFierce

@CarlyHFierce: Sanofi's statement on the latest bribery allegations in China: Statement | Follow @CarlyHFierce

> Roche chief's comments about deal discipline push shares up. Item

> LAT: Purdue keeps 'risky' OxyContin prescribers' names private. Article

> Sanofi 'confident' about China ops as officials launch bribery probe. Report

CRO News

> Covance offers service to keep contracts under control. Item

> ScinoPharm, Sundia team up in China. Report

> Parexel bets big on the future as revenue swells. Story

> AMRI swings to red despite another sales jump. More

> InVentiv takes aim at blockbusters with biosimilar deal. Article

Biotech IT News

> Medidata to score $287.5M in major financing. News

> CollabRx elbows into software game for gene interpretation. More

> Roche rolls out updated software for next-generation sequencing. Report

> Big Data analysis outfit GNS teams with Inova on predicting preterm birth. Story

> Gene by Gene acquires software upstart Arpeggi. Article